Managing progressive disease in patients with GIST: factors to consider besides acquired secondary tyrosine kinase inhibitor resistance. [electronic resource]
Producer: 20120808Description: 467-72 p. digitalISSN:- 1532-1967
- Benzamides
- Disease Progression
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm
- Gastrointestinal Neoplasms -- drug therapy
- Gastrointestinal Stromal Tumors -- drug therapy
- Humans
- Imatinib Mesylate
- Indoles -- therapeutic use
- Patient Compliance
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- therapeutic use
- Pyrroles -- therapeutic use
- Sunitinib
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.